Table 3. Sample description for the tumor and normal biopsies used for miRNA profiling.
Samples | Disease | Subtype | EBER | EBV latency |
---|---|---|---|---|
BL_001 | BL | Sporadic | NEG | NA |
BL_002 | BL | Sporadic | NEG | NA |
BL_003 | BL | Sporadic | NEG | NA |
BL_004 | BL | Sporadic | NEG | NA |
BL_007 | BL | Sporadic | NEG | NA |
BL_008 | BL | Sporadic | NEG | NA |
BL_010 | BL | Sporadic | NEG | NA |
BL_012 | BL | Sporadic | NEG | NA |
BL_020 | BL | Endemic | NEG | NA |
BL_023 | BL | Immunodeficiency-related | NEG | NA |
BL_024 | BL | Immunodeficiency-related | NEG | NA |
BL_025 | BL | Immunodeficiency-related | NEG | NA |
BL_030* | BL | Immunodeficiency-related | NEG | NA |
BL_005 | BL | Sporadic | POS | Type I |
BL_006 | BL | Sporadic | POS | Type I |
BL_009 | BL | Sporadic | POS | Type I |
BL_011 | BL | Sporadic | POS | Type I |
BL_013 | BL | Sporadic | POS | Type I |
BL_014 | BL | Endemic | POS | Type I |
BL_015 | BL | Endemic | POS | Type I |
BL_016 | BL | Endemic | POS | Type I |
BL_017 | BL | Endemic | POS | Type I |
BL_018 | BL | Endemic | POS | Type I |
BL_019 | BL | Endemic | POS | Type I |
BL_021 | BL | Endemic | POS | Type I |
BL_022 | BL | Immunodeficiency-related | POS | Type I |
BL_026 | BL | Immunodeficiency-related | POS | Type I |
BL_027 | BL | Immunodeficiency-related | POS | Type I |
BL_028 | BL | Immunodeficiency-related | POS | Type I |
BL_029 | BL | Immunodeficiency-related | POS | Type I |
PTLD_031 | PTLD | DLBCL | POS | Type III |
PTLD_032 | PTLD | DLBCL | POS | Type III |
PTLD_033 | PTLD | DLBCL | POS | Type III |
PTLD_034 | PTLD | DLBCL | POS | Type III |
PTLD_035 | PTLD | DLBCL | POS | Type III |
MNC_036 | Lymphadenopathy | Lymphadenopathy | POS | Type I |
MNC_037 | Lymphadenopathy | Lymphadenopathy | POS | Type I |
Not used in miRNA profiling.
NA: not available